Realización de un Análisis Coste-Efectividad y Coste-Eficacia del Autocontrol del Tratamiento Anticoagulante Oral (Tao)

Investigadores participantes: Vázquez Polo Francisco José (IP). Periodo: 13/07/2016 – 12/07/2018. Ámbito: Nacional. Importe: 18.011,25€. Entidad financiadora: Roche Diagnostics S.L.U. (Empresas Privadas).

Instituto Universitario de Turismo y Desarrolo Economico Sostenible
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.